Regulation of Oklahoma’s Medical Marijuana Industry

Show Report Details

Summary of Policy Considerations and Agency Recommendations

Policy Considerations

The Legislature may consider the following policy changes:

  • Establish an Agency Advisory Committee, or comparable structure, that requires agencies to:
    • define their roles and responsibilities within the medical marijuana industry
    • further develop the missing processes within the industry
    • develop and deliver strategic plans
    • develop and measure Key Performance Indicators (KPIs), and
    • utilize MOU agreements for the budgeting of regulatory functions
  • Establish a legislative oversight body responsible for reviewing and approving strategic plans, KPIs, and for ongoing feedback related to medical marijuana regulation.
  • Utilize the legislative oversight body to review and approve KPIs for each regulatory entity and to tie information into decisions regarding apportionment of tax collections, as OMMA is a non-appropriated agency.
  • Require an independent operational assessment related to transitioning OMMA to a stand- alone state agency or independent commission.
  • Review best practices for tracking and responding to supply and demand needs.
  • Institute a moratorium on business licenses until such a time the State can fully develop and implement its regulatory framework and bring the industry into compliance.

Agency Recommendations

The Oklahoma Medical Marijuana Authority should:

  • Develop an annual Strategic Plan with quantifiable and attainable measures to evaluate its performance in regulating the medical marijuana industry. The report would be delivered at a time determined by the Legislature.
  • Enhance the data collected from medical marijuana business applications to obtain more in- formation on growth and changes in the industry, and to inform the review process.
  • Develop a more comprehensive supply chain management strategy, including process implementation for the upcoming seed-to-sale tool and other strategies for collecting quality data to inform the decision-making process.
  • Work to improve the quality, quantity, and transparency of available data for medical marijuana metrics to allow for future evidenced-based investments.
Back to Interactive

More Reports & Evaluations


Operational Assessment of the Oklahoma Ethics Commission

Operational Assessment of the Oklahoma Ethics Commission

Report: 24-296-01
Conduct an operational assessment of the Ethics Commission.



OSDE Disbursements

Oct 29, 2024
Education

Oklahoma State Department of Education Disbursements of Funds

Report: 24-265-03
Review disbursements related to each of the five funding areas:
• Title Funds
• School Resource Officer/School Security Funds
• Maternity Leave
• Inhalers
• Pay Raises for Teachers Employed at “Off-Formula” Schools



Health Care Authority: Review of Funding Sources

Health Care Authority: Review of Funding Sources

Report: 24-807-01
Conduct a review of all funding sources available to the Health Care Authority, identifying federal match levels of programs. Review revolving fund balances and purposes.